Future Directions: The integration of psychiatric scales (e.g., PHQ-9, GAD-7) with inflammatory biomarkers (CRP, IL-6) could improve diagnostic specificity, enabling differentiation between primary psychiatric disorders and inflammation-driven secondary conditions. This evidence concerns the gene IL6 and psychiatric disorder.